Cipher Pharmaceuticals Inc. (NASDAQ:CPHR) – Equities research analysts at Cormark decreased their Q1 2017 earnings per share (EPS) estimates for Cipher Pharmaceuticals in a note issued to investors on Monday. Cormark analyst D. Novak now forecasts that the firm will post earnings per share of $0.03 for the quarter, down from their previous forecast of […]
